ClearBridge LLC (Maryland)’s BioMarin Pharmaceuticals BMRN Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$67K	Hold	790	–	–	0.02%	71
2018 Q3	$77K	Hold	790	–	–	0.02%	73
2018 Q2	$74K	Hold	790	–	–	﹤0.01%	167
2018 Q1	$64K	Hold	790	–	–	﹤0.01%	171
2017 Q4	$70K	Hold	790	–	–	﹤0.01%	167
2017 Q3	$74K	Hold	790	–	–	﹤0.01%	168
2017 Q2	$72K	Hold	790	–	–	﹤0.01%	166
2017 Q1	$69K	Hold	790	–	–	﹤0.01%	170
2016 Q4	$65K	Hold	790	–	–	﹤0.01%	169
2016 Q3	$73K	Hold	790	–	–	﹤0.01%	169
2016 Q2	$61K	Hold	790	–	–	﹤0.01%	171
2016 Q1	$65K	Hold	790	–	–	﹤0.01%	169
2015 Q4	$83K	Sell	790 -12,900	-94%	-$1.35M	﹤0.01%	169
2015 Q3	$1.44M	Hold	13,690	–	–	0.03%	148
2015 Q2	$1.87M	Buy	13,690 +800	+6%	+$99.1K	0.03%	141
2015 Q1	$1.61M	Hold	12,890	–	–	0.03%	145
2014 Q4	$1.17M	Hold	12,890	–	–	0.02%	151
2014 Q3	$930K	Hold	12,890	–	–	0.02%	154
2014 Q2	$802K	Hold	12,890	–	–	0.02%	160
2014 Q1	$879K	Sell	12,890 -5,510	-30%	-$406K	0.02%	150
2013 Q4	$1.29M	Hold	18,400	–	–	0.02%	144
2013 Q3	$1.33M	Hold	18,400	–	–	0.03%	134
2013 Q2	$1.03M	Buy	+18,400	New	+$1.15M	0.02%	174

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge LLC (Maryland)'s BMRN Position: Q4 2018 in Review

ClearBridge LLC (Maryland) held its BioMarin Pharmaceuticals (BMRN) position steady in Q4 2018 at 790 shares worth $67K. The position accounts for 0.02% of the portfolio, ranked #71.

ClearBridge LLC (Maryland) first reported a position in BMRN in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.87M in Q2 2015. 473 funds tracked by Wall St. Rank hold BMRN as of Q4 2018.

ClearBridge LLC (Maryland) held 790 shares of BioMarin Pharmaceuticals worth $67K as of Q4 2018.
ClearBridge LLC (Maryland) left its BioMarin Pharmaceuticals share count unchanged in Q4 2018.
BioMarin Pharmaceuticals made up 0.02% of ClearBridge LLC (Maryland)'s portfolio in Q4 2018, its #71 holding.
ClearBridge LLC (Maryland) first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
ClearBridge LLC (Maryland)'s BioMarin Pharmaceuticals position peaked at $1.87M in Q2 2015.
473 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2018, filed 14 Feb 2019.